Le Lézard
Classified in: Health, Science and technology, Business, Sports and recreation
Subject: LIC

CertaSite and Asher's Racing Channel announce winning partnership


Fire protection company sponsors kart racer for second year in a row

INDIANAPOLIS, May 2, 2024 /PRNewswire/ -- CertaSite®, a commercial fire protection and life safety company, today announced the continued sponsorship of kart racer Asher Farris of Asher's Racing Channel. The sponsorship will last through the 2024 season.

"CertaSite is thrilled to again be sponsoring Asher for the 2024 season," said Jeff Wyatt, CertaSite CEO. "There are big things ahead for Asher this season. To be able to support his dream and, at the same time, raise awareness for fire protection and life safety is a winning combination in my eyes."

Asher will complete with the Stars Championship Series this season. The first race of this series kicked off last weekend at Charlotte Motor Speedway where Asher raced against nearly 40 racers. In addition to Charlotte, NC, the Stars Championship Series will also take him to Cincinnati, OH, Mooresville, NC, and his home track of New Castle Motorsports Park in New Castle, IN.

This will be Asher's first season in the Mini Swift class for national races, a step up from his previous Micro Swift class. So far this season, Asher has five finishes including two first place finishes and a pole position.

"We can't thank CertaSite enough. To have them onboard supporting Asher for another season is so exciting," said the Farris family. "Last year was a great year, and we're expecting an even bigger one this season with CertaSite again as a sponsor. Asher and team can't wait to continue racing to save lives and bring more awareness to fire protection and life safety."

CertaSite is on a mission to provide a meaningful impact in as many lives as possible. From customers and their philanthropic arm CertaSite Serves to supporting dreams like Asher's, the company is hitting that mission every single day.

About CertaSite
CertaSite is a commercial fire protection and life safety company founded in 2018. We take a new approach to fire and life safety, going beyond compliance to give our clients an unmatched level of customer service and tech-based control over their fire and life safety systems. Our team of experts serves more than 20 locations. CertaSite is headquartered in Indianapolis. Visit www.certasitepro.com for more information.

SOURCE CertaSite


These press releases may also interest you

at 02:00
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...

at 01:54
RaySearch Laboratories: Interim report January 1 - March 31, 2024
FIRST QUARTER (JANUARY - MARCH 2024) Oder intake SEK 238.5 M (206.6)Net sales SEK 257.2 M (230.2)Operating profit SEK 45.8 M (23.7)Profit after tax SEK 36.7 M (17.6)Earnings per share before/after dilution SEK 1.07 (0.51)Cash flow SEK 87.9 M...

at 01:00
Luraco Technologies Introduces the New i9 Max Plus Series with Advanced Features for Ultimate Comfort and Therapeutic Massage
In response to valuable feedback from our customers, Luraco Technologies is thrilled to announce the launch of an upgrade to our medical massage chair lineup. We are introducing the Luraco i9 Max Plus Series, a revolution of the i9 Max Series. The i9...

at 00:01
Celltrion USA announces two-year data for ZYMFENTRAtm(infliximab-dyyb) to be presented at Digestive Disease Week (DDW) 2024 Conference
Celltrion USA today announced it will present the two-year results from the extended LIBERTY studies (LIBERTY-CD and LIBERTY-UC) in adult patients...

16 mai 2024
Proteologix, Inc. to be Acquired by Johnson & Johnson
Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson for $850 million in cash,...

16 mai 2024
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
Seelos Therapeutics, Inc. ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system ("CNS") disorders and rare diseases, announced today that it has entered into a...

More news about Health...


News published on and distributed by: